Huber, K., Aylward, P. E., Van’T Hof, A. W., Montalescot, G., Holmes, D. R., Betriu, G. A., … Armstrong, P. W. (2007). Glycoprotein IIb/IIIa inhibitors before primary percutaneous coronary intervention of ST-elevation myocardial infarction improve perfusion and outcomes: Insights from APEX-AMI. In CIRCULATION (Vol. 116, pp. 673–673). Orlando, FL: LIPPINCOTT WILLIAMS & WILKINS.

Huber, Kurt, Philip E. Aylward, Arnoud W. Van’T Hof, Gilles Montalescot, David R. Holmes, G. A. Betriu, Petr Widimsky, Cynthia M. Westerhout, Christopher B. Granger, and Paul W. Armstrong. “Glycoprotein IIb/IIIa inhibitors before primary percutaneous coronary intervention of ST-elevation myocardial infarction improve perfusion and outcomes: Insights from APEX-AMI.” In CIRCULATION, 116:673–673. LIPPINCOTT WILLIAMS & WILKINS, 2007.

Huber K, Aylward PE, Van’T Hof AW, Montalescot G, Holmes DR, Betriu GA, et al. Glycoprotein IIb/IIIa inhibitors before primary percutaneous coronary intervention of ST-elevation myocardial infarction improve perfusion and outcomes: Insights from APEX-AMI. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2007. p. 673–673.

Huber, Kurt, et al. “Glycoprotein IIb/IIIa inhibitors before primary percutaneous coronary intervention of ST-elevation myocardial infarction improve perfusion and outcomes: Insights from APEX-AMI.” CIRCULATION, vol. 116, no. 16, LIPPINCOTT WILLIAMS & WILKINS, 2007, pp. 673–673.

Huber K, Aylward PE, Van’T Hof AW, Montalescot G, Holmes DR, Betriu GA, Widimsky P, Westerhout CM, Granger CB, Armstrong PW. Glycoprotein IIb/IIIa inhibitors before primary percutaneous coronary intervention of ST-elevation myocardial infarction improve perfusion and outcomes: Insights from APEX-AMI. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2007. p. 673–673.